Foretinib demonstrates anti-tumor activity and improves overall survival in preclinical models of hepatocellular carcinoma. [electronic resource]
Producer: 20120530Description: 59-70 p. digitalISSN:- 1573-7209
- Anilides -- pharmacology
- Animals
- Antineoplastic Agents -- therapeutic use
- Apoptosis -- drug effects
- Carcinoma, Hepatocellular -- blood supply
- Cell Cycle -- drug effects
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Disease Models, Animal
- Dose-Response Relationship, Drug
- Humans
- Liver Neoplasms -- blood supply
- Male
- Mice
- Mice, SCID
- Neovascularization, Pathologic -- drug therapy
- Quinolines -- pharmacology
- Survival Analysis
- Time Factors
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.